+5 year(s) experience
In her role, Zara creates and publishes current, client-focused content including comments, KOL interviews andsurveys, conference reports and webinars.
Prior to joining Informa in 2016, Zara worked as a scientist at The Janssen Pharmaceutical Companies of Johnson & Johnson. While there she worked on a vaccine for Alzheimer's disease. During her time as a Postdoctoral Research Associate at The Scripps Research Institute, she worked on a vaccine for HIV.
With her training as a Structural Biologist, Zara is able to provide insight into the mechanicism of action of drugs in clinical development at the molecular level.
Alnylam’s high stakes investment in RNAi therapeutics delivers a major short-term win for stakeholders, but long-term commercial success is still in question.
Allergan’s deal with the Saint Regis Mohawk Tribe will shore up revenue from its top-selling dry eye drug Restasis in the short term.
Topic Company analysis